Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E. I. Gulo"'
Publikováno v:
Journal of obstetrics and women's diseases. 50:57-60
The aim of the investigation was to study the role of diagnostic laparoscopy in treatment of patients with ovarian cancer. The analysis of 480 laparoscopic operations, which was carried out on 42 patients with benign tumors, 29 cases of suspected tum
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 71:79-83
To determine optimal indications for and clinical assessment of the significance of relaparotomy, the data of 304 women with malignant ovarian tumours (of epithelial origin, predominantly, 72%) who had undergone a 'second-look' operation were analyse
Publikováno v:
Voprosy onkologii. 50(6)
A clinical appraisal of efficacy and tolerability of taxol (T) and a generic drug--paclitaxel--LANCE (P)--was carried out in two groups of patients with recurrences (9) or platinum-refractory ovarian carcinoma (17). In group I, patients aged 19-71 (m
Publikováno v:
Voprosy onkologii. 44(2)
The data on 503 cases of ovarian malignancies were evaluated to work out indications for and clinical assessment of revision laparotomies. Second-look surgery was carried out in the following situations: (1) tumor elements found in the washings of th
Publikováno v:
Voprosy onkologii. 43(3)
Retroperitoneal lymphatic cysts account for 10.0-15.0% of complications of extended hysterectomy for tumors of the cervix uteri and endometrium. The data on 1,093 cases treated at the Institute Clinic in 1980-1994 have been analyzed to establish retr
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. Supplement. 155
To determine optimal indications for and clinical assessment of the significance of relaparotomy, the data of 304 women with malignant ovarian tumours (of epithelial origin, predominantly, 72%) who had undergone a 'second-look' operation were analyse
Publikováno v:
Voprosy onkologii. 38(5)
Data on 304 patients with ovarian malignancies (mostly epithelial-72.0%) who had undergone second-look surgery were analysed to develop indications and assess the clinical value of the procedure. Second-look operations were performed 10-22 months aft